$5.75
-0.23 (-3.85%)
Halozyme Therapeutics, Inc. (HALO)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

RSS Headlines
Fool UK